PD-MitoQUANT PI Ronald Melki of the Centre National de la Recherche Scientifique (CNRS) recently delivered the plenary lecture of the Frontiers in Neuroscience session of the American Academy of Neurology (AAN) annual meeting on May 8, 2019, in Philadelphia, USA. Through his talk, PD-MitoQUANT funding was acknowledged. The theme of the 71st AAN annual meeting was "Advancing Neurology, Advancing You". It was held May 4- 10th. The meeting offers unparalleled opportunities for professional and personal advancement at the world’s largest gathering of [...]
PD-MitoQUANT recently appeared in the news stream of HealthEuropa.eu. Read the story, “The Innovative Medicines Initiative, mitochondrial dysfunction and Parkinson’s". Read the story here. Health Europa highlights the latest trends and developments in health and healthcare from across Europe. Their platform is a valuable news source to the health sector, allowing them to discuss research and innovation themes, health policy and new technologies. In addition, the website, HealthEuropa.eu has gained Google News approval. It features news, interviews and insightful commentary from leading figures, keeping readers [...]
Here is a list of international and national media coverage of the launch of PD-MitoQUANT: Bioengineer.org: Ireland to lead €7 million Parkinson's research project. Read the story here. SCIENMAG: Ireland to lead €7 million Parkinson's research project. Read the story here. Hospital Pharmacy Europe: Ireland to lead on €7 million Parkinson's research project. Read the story here. Bio Spectrum Asia: Ireland to lead €7 M Parkinson's research project. Read the story here. SiliconRepublic.com: Ireland’s RCSI to lead €7m Parkinson’s research project. Read the story here. Irish Mirror: €7m [...]
7 million euro awarded for Parkinson’s research through Innovative Medicines Initiative New, more effective treatments are urgently needed for the more than one million people living with Parkinson’s in Europe today. While there are therapies available for the condition, they do not improve all symptoms, nor do they slow or prevent disease progression over time, and long-term treatment is associated with adverse side effects. PD-MitoQUANT (www.pdmitoquant.eu) is an Innovative Medicines Initiative (IMI - www.imi.europa.eu) research project that will improve [...]
The team at RCSI in Dublin, Ireland are hiring for a post-doctoral position in Parkinson’s research. A two-year full-time Post-Doctoral position is now available in the Centre for Systems Medicine (CSM) and the Department of Physiology and Medical Physics, RCSI (Royal College of Surgeons in Ireland), utilising molecular and cell imaging techniques to investigate the role of mitochondrial dysfunction in Parkinson’s. Check out our Vacancies page for more information!